Sphera Funds Management Ltd. Syndax Pharmaceuticals Inc Transaction History
Sphera Funds Management Ltd.
- $380 Million
- Q1 2025
A detailed history of Sphera Funds Management Ltd. transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Sphera Funds Management Ltd. holds 1,663,974 shares of SNDX stock, worth $17.2 Million. This represents 5.38% of its overall portfolio holdings.
Number of Shares
1,663,974
Previous 1,381,241
20.47%
Holding current value
$17.2 Million
Previous $18.3 Million
11.99%
% of portfolio
5.38%
Previous 3.76%
Shares
24 transactions
Others Institutions Holding SNDX
# of Institutions
237Shares Held
101MCall Options Held
1.36MPut Options Held
618K-
Kynam Capital Management, LP Princeton, NJ8.52MShares$88.2 Million8.82% of portfolio
-
Black Rock Inc. New York, NY7.91MShares$81.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.87MShares$50.4 Million0.0% of portfolio
-
Eversept Partners, LP New York, NY4.21MShares$43.6 Million5.73% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct4.01MShares$41.5 Million0.12% of portfolio
About Syndax Pharmaceuticals Inc
- Ticker SNDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,565,200
- Market Cap $585M
- Description
- Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...